Avastin In AMD: French Court Verdict Imminent
This article was originally published in Scrip
Executive Summary
France's top administrative court, the Conseil d'Etat, is expected to decide any day now whether to suspend the government's decision to reimburse the off-label use of Roche's anticancer, Avastin (bevacizumab), in wet AMD.